HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patricia A Rayman Selected Research

Triple Negative Breast Neoplasms

10/2023Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patricia A Rayman Research Topics

Disease

7Neoplasms (Cancer)
10/2023 - 03/2009
5Renal Cell Carcinoma (Grawitz Tumor)
10/2019 - 03/2009
1Triple Negative Breast Neoplasms
10/2023
1Ovarian Neoplasms (Ovarian Cancer)
01/2023
1Inflammation (Inflammations)
01/2019
1Carcinoma (Carcinomatosis)
10/2018

Drug/Important Bio-Agent (IBA)

3CytokinesIBA
01/2023 - 01/2019
2LigandsIBA
01/2024 - 10/2018
2Immune Checkpoint InhibitorsIBA
10/2018 - 09/2018
2Sunitinib (Sutent)FDA Link
01/2012 - 03/2009
1130-nm albumin-bound paclitaxelIBA
10/2023
1pembrolizumabIBA
10/2023
1Carboplatin (JM8)FDA LinkGeneric
10/2023
1Interleukin-12 (IL 12)IBA
01/2023
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
10/2019
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2019
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2019
1Inflammation MediatorsIBA
10/2019
1CXC ChemokinesIBA
10/2019
1ChemokinesIBA
10/2019
1Biomarkers (Surrogate Marker)IBA
09/2018
1GangliosidesIBA
04/2009

Therapy/Procedure

4Therapeutics
10/2023 - 03/2009
2Immunotherapy
10/2023 - 01/2023
1Drug Therapy (Chemotherapy)
10/2023
1Nephrectomy
09/2018